Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing

NACompletedINTERVENTIONAL
Enrollment

19,113

Participants

Timeline

Start Date

January 7, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
OTHER

Proactive Outreach

"The treatment is proactive outreach that sought to enroll individuals in a VBID program available to all enrollees that provided: 1) large reductions in cost-sharing for maintenance inhalers, and 2) telephone-based COPD medication management services.~Proactive outreach for those randomized to the treatment arm included, at a minimum, a phone call and letter in the mail from Humana. Proactive outreach could also have included an email, text message, and/or provider referral."

OTHER

No Proactive Outreach

Control group participants received no proactive outreach but could call to enroll themselves in the VBID program if they learned about it through traditional means, such as the benefits description manual.

Trial Locations (3)

40202

Humana, Inc., Louisville

60637

University of Chicago, Chicago

02115

Harvard Medical School, Boston

All Listed Sponsors
collaborator

Humana Co.Ltd.

INDUSTRY

lead

Harvard Medical School (HMS and HSDM)

OTHER

NCT05497999 - Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing | Biotech Hunter | Biotech Hunter